Skip to content

EPIRUS Biopharmaceuticals, Inc.: filings

Every EPIRUS Biopharmaceuticals, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 20 filings, each linked to its SEC index.

Filing record ends 2016-05-10

The latest filing in this captured record is a 10-Q filed 2016-05-10. No later filing is in the SEC companyfacts record captured on 2026-09-22. EPIRUS Biopharmaceuticals, Inc. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2016-05-10fiscal Q1 201634700001558370-16-005832
10-K2016-03-29fiscal FY 201537730001558370-16-004428
10-Q2015-11-16fiscal Q3 201536900001558370-15-002703
10-Q2015-08-12fiscal Q2 201532850001104659-15-059110
10-Q2015-05-13fiscal Q1 201533650001104659-15-037740
10-K2015-03-31fiscal FY 201434640001047469-15-002966
10-Q2014-11-10fiscal Q3 201431780001104659-14-079030
10-Q2014-08-11fiscal Q2 201434850001193125-14-305036
10-Q2014-05-09fiscal Q1 201432620001193125-14-192405
10-K2014-03-14fiscal FY 2013371750001193125-14-098834
10-Q2013-11-04fiscal Q3 201335910001193125-13-425201
10-Q2013-08-05fiscal Q2 201335920001193125-13-319056
10-Q2013-05-03fiscal Q1 201334680001193125-13-199110
10-K2013-03-07fiscal FY 2012391810001193125-13-096030
10-Q2012-11-08fiscal Q3 201235930001193125-12-460462
10-Q2012-08-07fiscal Q2 201235910001193125-12-339446
10-Q2012-05-04fiscal Q1 201234700001193125-12-211968
10-K2012-03-09fiscal FY 201138990001193125-12-106018
10-Q2011-11-04fiscal Q3 201135870001193125-11-297359
10-Q2011-08-04fiscal Q2 201135860001193125-11-210415

Inspect the source

Entity
EPIRUS Biopharmaceuticals, Inc. / CIK 0001135906
Captured
SEC response SHA-256
87f8224528d5be267378d02137fa575d4041842bd702d7de7999c10c2349849b

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001135906.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))